You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 35 No. 11, November 1978 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Huntington's Disease

Cerebrospinal Fluid GABA Levels in At-risk Individuals

N. V. Bala Manyam, MD; Theodore A. Hare, PhD; Leonard Katz, MD; Bruce S. Glaeser, PhD

Arch Neurol. 1978;35(11):728-730.


Abstract

• Gamma-aminobutyric acid (GABA) was measured by the ion-exchange fluorometric method in CSF from 22 individuals at risk for Huntington's disease (HD), six individuals with HD, and five neurologically normal controls. The mean (± SD) GABA level in the specimens from patients with HD was 142 ± 27 pmoles/ ml, whereas that of the normal control specimens was 297 ± 87 pmoles/ml. The mean GABA level of the specimens from the individuals at risk for HD was 209 ± 79 pmoles/ml; however, nine of these were in the normal range with a mean value of 281 ± 72 pmoles/ml, while the other 13 were below the normal range with a mean value of 159 ± 27 pmoles/ ml. The data indicate that low GABA levels in CSF are evident prior to the onset of symptoms of HD but a predictive value can only be determined by continued observation of the clinical course of these at-risk individuals.



Author Affiliations

From the Neurology Service, Veterans Administration Center, Wilmington, Del (Drs Manyam and Katz); and the Departments of Neurology (Drs Manyam and Katz) and Pharmacology (Drs Hare and Glaeser), Jefferson Medical College of Thomas Jefferson University, Philadelphia. Dr Glaeser is now with the Massachusetts Institute of Technology, Cambridge.


Footnotes

Accepted for publication June 12, 1978.

Reprint requests to Neurology Service, Veterans Administration Center, Wilmington, DE 19805 (Dr Manyam).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Central Nervous System {gamma}-Aminobutyric Acid Activity in Man: Relationship to Age and Sex as Reflected in CSF
Hare et al.
Arch Neurol 1982;39:247-249.
ABSTRACT  

Clinical Implications of Enzyme-Mediated Alterations of {gamma}-Aminobutyric Acid Content in Human CSF
Hare et al.
Arch Neurol 1981;38:491-494.
ABSTRACT  

Levels of {gamma}-Aminobutyric Acid in Cerebrospinal Fluid in Various Neurologic Disorders
Manyam et al.
Arch Neurol 1980;37:352-355.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.